In Brief: NAD Decisions, Warning Letters, EC Law Struck, “Natural” Claims Suit
This article was originally published in The Tan Sheet
Executive Summary
Pharmavite discontinues ads; NAD looks at supplement concussion claims; FDA warns product requires NDI; Spinal Touch Formulas are unapproved new drugs – FDA; Weight-loss products unapproved, misbranded; Oklahoma law restricting contraception knocked down; and Hammer Nutrition sued over “natural” claims
You may also be interested in...
Claims Emerge To Join “Natural” As Class Action Fodder
Claims a product is “natural,” health and prevention claims, “whole grain” and “made with” claims, all can put a firm at risk for a lawsuit, the Center for Science in the Public Interest warns. After climbing for five years in a row, class action lawsuits brought against food products dipped in 2013, but the decline may be short-lived.
Spiked “Supplements” For Diabetes, Pain On The Rise
FDA is seeing supplements spiked with Rx ingredients indicated for pain management and diabetes treatment, and needs industry help identifying violators, CFSAN head Michael Landa says.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.